Pro Rata Rights at Pre-Seed: What You Give Away and What It Costs at Series A

Pro rata rights give a pre-seed investor the option to invest more at your next round to maintain their ownership percentage. They cost you nothing at signing. The cost lands at Series A, when those rights claim part of the allocation your lead investor wants, forcing you to expand the round or dilute further.

That gap between when you grant it and when you pay for it is why this term gets waved through. Every other line in a SAFE negotiation has an immediate, visible price. Move the cap from $8M to $10M and you can see exactly what it does to your ownership. Grant pro rata and nothing happens. No number changes. The cap table looks identical the next morning.

Eighteen months later it is the reason your Series A lead is asking why they can only get 17 percent.

Why pro rata is not in your SAFE

The standard post-money SAFE does not include pro rata rights. That is deliberate, and understanding why tells you how to handle the ask.

As Chris Neumann explains in his piece on why pre-seed investors ask for side letters, the simplicity of the SAFE came in part from removing clauses that were not particularly important to angel investors but matter a lot to VCs. Pro rata is the main one. Angels rarely ask for it, because they usually do not have the capital to follow on. VCs treat maintaining ownership as key to generating returns for their own investors.

So the SAFE got simple by stripping out the VC-relevant terms, and the side letter is where VCs put them back. When a fund asks for a pro rata side letter, they are not being aggressive. They are restoring a term their business model depends on.

Neumann makes a point worth registering. Through the hot market of 2017 to 2021, early-stage VCs often invested without these protections rather than lose deals, against their own long-term interests. As conditions recalibrated, they reasserted them. If you are raising now and hearing about side letters more than a founder friend did in 2021, nothing is wrong with your round. The market moved back.

What it actually costs

The mechanism is allocation, not dilution. That distinction is the whole article.

Your Series A lead is buying a target ownership percentage. Call it 20 percent. They are not buying a dollar amount, they are buying a position, and the dollar amount is whatever it takes to get there. Pro rata rights give your existing investors a contractual claim on part of that same 20 percent.

As CRV puts it in their guide to SAFE agreements, these rights can consume allocation that would otherwise go to your Series A lead, who often wants meaningful ownership. Now you have three options and none is free:

Read those three again. Every path costs you something, and you are choosing between them during the highest-stakes negotiation of your company's life, over a term you granted for free eighteen months earlier.

That is what "costs nothing at signing" actually means. It means the cost is deferred to the exact moment you can least afford it.

The same round, with and without scoping

Numbers make this concrete. Take a founder who raises $1.5M at pre-seed on post-money SAFEs at a $10M cap. Five investors, and every one asks for pro rata. Round one of the story: she says yes to all five, no limits, because none of it costs anything today.

At a $10M post-money cap, that $1.5M converts to roughly 15 percent for the SAFE holders in aggregate. Eighteen months later she raises a Series A. The lead wants 20 percent.

Here is the squeeze. Her SAFE holders hold pro rata claims proportional to that 15 percent position. If most of them exercise, they have a claim on a meaningful slice of the new round, and the lead's 20 percent and the SAFE holders' claims are competing for the same equity. She now runs the waiver calls, mid-deal, needing yes from people who have no obligation to give it.

Now run it scoped. Same round, same $1.5M, same five investors. Pro rata goes to the two who wrote $500K and $400K, limited to the next financing only. Their combined post-conversion position is around 9 percent, so their claim on the Series A is a fraction of what the lead needs, and it fits inside the round without expanding it.

Same money raised. Same investors. Same valuation. The only difference is two sentences in a side letter, written eighteen months before anybody felt the consequence.

Note what did not change: she did not raise less, pay a lower cap, or lose a single investor. Scoping pro rata is not a concession you trade something for. It is free, and it is only free before you sign.

The threshold that does most of the work

The fix is not refusing pro rata. It is scoping it. Two constraints carry nearly all the value.

Only your largest investors. The 1984 Ventures founders handbook on SAFE side letters treats pro rata as a fairly common ask for investors writing $500K or more at seed. That framing is useful: pro rata is a term for people making a real bet, not everyone on your cap table. A $25K angel with pro rata rights is a rounding error that still consumes allocation and still needs a waiver conversation.

Only the next round. Both 1984 and CRV land in the same place, and this is the one to fight for. Limit the right to the next financing only, never perpetual. Perpetual pro rata means an investor who wrote a $500K check at pre-seed has a standing claim on every round through Series C. You are not just giving away Series A allocation. You are giving away allocation in rounds you cannot imagine yet, on terms set when your company was three people and a prototype.

The good news: both constraints are standard. Asking for them does not make you difficult. A fund that will not limit pro rata to the next round is telling you something about how they will behave later.

The terms that should just be no

1984's handbook keeps a short avoid list, and one item deserves particular attention.

Super pro rata lets an investor buy more than their current percentage in your next round. Read that slowly. An investor who owns 4 percent gets to buy up to, say, 10 percent of your Series A, on a right they locked in when you had no traction and no negotiating power. It converts an early check into a standing option on your best future round. At pre-seed, this is a no.

The rest of the avoid list is worth knowing: advisory shares bundled into a side letter, liquidation preferences beyond 1x, and guaranteed returns. None of these belong in a pre-seed side letter, and all of them show up occasionally.

One more from 1984 that founders sign without thinking: information rights. Their guidance is blunt and correct. Do not sign up for something you do not want to do, like monthly financials or audited statements if you are not working with an auditor. Quarterly is normal and VCs genuinely need it for fiduciary duties. Monthly audited financials at pre-seed is a commitment you will break by month four, and breaking it is a covenant problem you invented for yourself.

If pro rata is showing up alongside MFN and other side-letter terms in your round, how MFN and side letters actually work across multiple SAFEs covers how they interact once you have several investors at different caps. The interaction is where it gets genuinely hard.

Do the arithmetic before you sign

Here is the exercise almost no first-time founder runs, and it takes ten minutes.

Take every investor you plan to grant pro rata. Estimate their post-conversion ownership. Sum it. That sum is roughly the share of your Series A they have a claim on. Now put it next to your lead's likely target of about 20 percent and ask whether both fit.

If your pro rata holders come to 6 or 7 percent and your lead wants 20, you are fine. If they come to 15 percent, you have a structural problem that exists today and surfaces in eighteen months. The number you want is small enough that you never have to make the waiver call.

This is the same discipline as sizing the round itself. You pick a number by working backward from the outcome you need, not forward from what feels reasonable in the moment. How much to raise at pre-seed works that logic on the round size, and pro rata deserves the same treatment: a term you scope against a future round you have actually modeled, not one you agree to because the investor seemed reasonable and it did not appear to cost anything.

And if you are stacking several SAFEs, run it with the conversions modeled properly. Pro rata claims scale with post-conversion ownership, which is not what you think it is until you build the dilution math round by round.

What to actually say

When a pre-seed investor asks for pro rata, the answer is not no, and it is not an unqualified yes.

It is: yes, limited to the next round, for investors at or above a threshold. That sentence is standard, defensible, and will not cost you a deal with a fund worth taking money from. If a fund pushes for perpetual or super pro rata, you have learned something useful early and cheaply.

The founders who get hurt here are not the ones who negotiated badly. They are the ones who never negotiated at all, because the term did not appear to cost anything and the SAFE was already signed. Every other line had a number attached. This one had a blank, and the blank got filled in at Series A.

Scope it now. It is a five-minute conversation today and a very expensive one later. That asymmetry, between terms that bill immediately and terms that bill at the worst possible moment, is most of what separates founders who keep their ownership from founders who wonder where it went. It is the throughline of The Funding Framework, and pro rata is the cleanest example of it in a pre-seed round.